[
  {
    "ts": "2025-07-15T17:56:28+00:00",
    "headline": "Simulations Plus Sees Weaker Demand Persist, Outlook Softens",
    "summary": "Simulations Plus Inc. (NASDAQ:SLP) shares declined on Tuesday following the release of its third-quarter 2025 earnings report. The company reported sales of $20.4 million, representing a 10% year-over-year increase, but this fell short of the consensus estimate of $20.9 million. This miss followed preliminary third-quarter sales figures released in June, which were already lower than expectations at $19 million to $20 million, compared to a consensus of $22.78 million. Also Read: What’s Going On",
    "url": "https://finance.yahoo.com/news/simulations-plus-sees-weaker-demand-175628118.html",
    "source": "Benzinga",
    "provider": "yfinance",
    "raw": {
      "id": "18687d61-b2e1-3ec0-9466-5af9a7082e47",
      "content": {
        "id": "18687d61-b2e1-3ec0-9466-5af9a7082e47",
        "contentType": "STORY",
        "title": "Simulations Plus Sees Weaker Demand Persist, Outlook Softens",
        "description": "",
        "summary": "Simulations Plus Inc. (NASDAQ:SLP) shares declined on Tuesday following the release of its third-quarter 2025 earnings report. The company reported sales of $20.4 million, representing a 10% year-over-year increase, but this fell short of the consensus estimate of $20.9 million. This miss followed preliminary third-quarter sales figures released in June, which were already lower than expectations at $19 million to $20 million, compared to a consensus of $22.78 million. Also Read: What’s Going On",
        "pubDate": "2025-07-15T17:56:28Z",
        "displayTime": "2025-07-15T17:56:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Benzinga/579239de4e211e56933499e5d4f9a854",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "Simulations Plus Sees Weaker Demand Persist, Outlook Softens",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A6z6FWKPxX98kR1b141j0g--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/579239de4e211e56933499e5d4f9a854.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kvHrvIt9jlG8O.YJYbVVgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Benzinga/579239de4e211e56933499e5d4f9a854.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Benzinga",
          "url": "http://www.benzinga.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/simulations-plus-sees-weaker-demand-175628118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/simulations-plus-sees-weaker-demand-175628118.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SLP"
            },
            {
              "symbol": "CRL"
            },
            {
              "symbol": "CERT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-15T13:51:35+00:00",
    "headline": "Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes",
    "summary": "Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The equity portfolio returned 4.67% in the second quarter compared to 10.94% for the S&P 500 Index. An underweight in technology stocks and an overweight in value and mid-cap stocks […]",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-crl-135135604.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "7706a2fa-a05d-3d2f-aa03-5919e80898f7",
      "content": {
        "id": "7706a2fa-a05d-3d2f-aa03-5919e80898f7",
        "contentType": "STORY",
        "title": "Charles River Laboratories International (CRL) is Expected to Gain as Industry Growth Resumes",
        "description": "",
        "summary": "Oakmark Funds, advised by Harris Associates, released its “Oakmark Equity and Income Fund” Q2 2025 investor letter. A copy of the letter can be downloaded here. The equity portfolio returned 4.67% in the second quarter compared to 10.94% for the S&P 500 Index. An underweight in technology stocks and an overweight in value and mid-cap stocks […]",
        "pubDate": "2025-07-15T13:51:35Z",
        "displayTime": "2025-07-15T13:51:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Charles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/brh3fJuygdiS8j7qgVO3lQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FkjVFWm.A9_NXt5p9KTolg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/0e857ae9b0144d1996b14fb908ea3840.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-crl-135135604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-international-crl-135135604.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-15T12:00:00+00:00",
    "headline": "Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call",
    "summary": "WILMINGTON, Mass., July 15, 2025--Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-schedules-second-120000358.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "719938a1-55dc-34ec-8be4-d1fdd9933f14",
      "content": {
        "id": "719938a1-55dc-34ec-8be4-d1fdd9933f14",
        "contentType": "STORY",
        "title": "Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call",
        "description": "",
        "summary": "WILMINGTON, Mass., July 15, 2025--Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call",
        "pubDate": "2025-07-15T12:00:00Z",
        "displayTime": "2025-07-15T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/997c48dcfe8ef6d72bff8ab051a5e2d1",
          "originalWidth": 1245,
          "originalHeight": 326,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iIahqSYxUx2C52w4LuLKQw--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/997c48dcfe8ef6d72bff8ab051a5e2d1.cf.webp",
              "width": 1245,
              "height": 326,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DM_FZ2G6lmqHHwx0ceLEcQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/997c48dcfe8ef6d72bff8ab051a5e2d1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-schedules-second-120000358.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-schedules-second-120000358.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]